Evidence map›Paper›PMID 34686921›Full record

ArticleEnvironmental geochemistry and health2022

In vitro and in vivo assessment of a CLD sequestration strategy in Nitisol using contrasted carbonaceous materials.

Cyril Feidt, Nadine El Wanny, Ronald Ranguin, Sarra Gaspard, Moomen Baroudi, Christelle Yacou, Guido Rychen, Matthieu Delannoy

Abstract read
PubMed Publisher
In one paragraph

Article in Environmental geochemistry and health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 4 countries.

Cyril FeidtUniversité de Lorraine, INRAE, UR AFPA , F-54000 , Nancy, France.
Nadine El WannyUniversité de Lorraine, INRAE, UR AFPA , F-54000 , Nancy, France.
Ronald RanguinLaboratoire COVACHIMM2E, EA 3592, Université des Antilles, BP 250, 97157, Pointe à Pitre Cedex, Guadeloupe , France.
Sarra GaspardLaboratoire COVACHIMM2E, EA 3592, Université des Antilles, BP 250, 97157, Pointe à Pitre Cedex, Guadeloupe , France.
Moomen BaroudiFaculty of Public Health-Section III, L.S.E.E, Lebanese University, BP 246, Tripoli, Lebanon.
Christelle YacouLaboratoire COVACHIMM2E, EA 3592, Université des Antilles, BP 250, 97157, Pointe à Pitre Cedex, Guadeloupe , France.
Guido RychenUniversité de Lorraine, INRAE, UR AFPA , F-54000 , Nancy, France.
Matthieu DelannoyUniversité de Lorraine, INRAE, UR AFPA , F-54000 , Nancy, France. matthieu.delannoy@univ-lorraine.fr.ORCID http://orcid.org/0000-0002-9699-6513
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement · FRUniversité des Antilles · GPLebanese University · LB

Funding

Agence Nationale de la Recherche ANR-16-CE21-0008
6 · The paper itself

Abstract

Chlordecone (Kepone) (CLD) is a highly persistent pesticide formerly used in the French West Indies. High levels of this pesticide may be found in soils and constitute a subsequent source of contamination for outdoor-reared animals due to involuntary ingestion of consistent amounts of soil. In that context, carbonaceous materials may be used to amend soil to efficiently decrease the bioavailability of such organic pollutants. The present study aims to assess the efficiency of diverse amendments of a contaminated Guadeloupe nitisol using two physiologically based approaches. A set of 5 carbonaceous materials (ORBO, DARCO, Coco CO

Indexed as

ChlordeconeSoil PollutantsAnimalsInsecticidesSwineChlordeconeInsecticidesSoil PollutantsBioaccessibilityBioavailabilityChlordeconeExposureSequestration

Identifiers

PMID34686921
OpenAlexW3205472868

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.